Cavenagh Health Limited 07341143 false 2023-01-01 2023-12-31 2023-12-31 The principal activity of the company is Other human health activities Digita Accounts Production Advanced 6.30.9574.0 true true 07341143 2023-01-01 2023-12-31 07341143 2023-12-31 07341143 core:HirePurchaseContracts core:CurrentFinancialInstruments 2023-12-31 07341143 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2023-12-31 07341143 core:CurrentFinancialInstruments 2023-12-31 07341143 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 07341143 core:Non-currentFinancialInstruments 2023-12-31 07341143 core:Non-currentFinancialInstruments core:AfterOneYear 2023-12-31 07341143 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-12-31 07341143 core:FurnitureFittingsToolsEquipment 2023-12-31 07341143 core:MotorVehicles 2023-12-31 07341143 bus:SmallEntities 2023-01-01 2023-12-31 07341143 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 07341143 bus:FullAccounts 2023-01-01 2023-12-31 07341143 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 07341143 bus:RegisteredOffice 2023-01-01 2023-12-31 07341143 bus:Director1 2023-01-01 2023-12-31 07341143 bus:Director2 2023-01-01 2023-12-31 07341143 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 07341143 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-01-01 2023-12-31 07341143 core:FurnitureFittingsToolsEquipment 2023-01-01 2023-12-31 07341143 core:MotorVehicles 2023-01-01 2023-12-31 07341143 core:OfficeEquipment 2023-01-01 2023-12-31 07341143 countries:EnglandWales 2023-01-01 2023-12-31 07341143 2022-12-31 07341143 core:FurnitureFittingsToolsEquipment 2022-12-31 07341143 core:MotorVehicles 2022-12-31 07341143 2022-01-01 2022-12-31 07341143 2022-12-31 07341143 core:HirePurchaseContracts core:CurrentFinancialInstruments 2022-12-31 07341143 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2022-12-31 07341143 core:CurrentFinancialInstruments 2022-12-31 07341143 core:CurrentFinancialInstruments core:WithinOneYear 2022-12-31 07341143 core:CurrentFinancialInstruments core:WithinOneYear core:PreviouslyStatedAmount 2022-12-31 07341143 core:Non-currentFinancialInstruments 2022-12-31 07341143 core:Non-currentFinancialInstruments core:AfterOneYear 2022-12-31 07341143 core:FurnitureFittingsToolsEquipment 2022-12-31 07341143 core:MotorVehicles 2022-12-31 07341143 core:PreviouslyStatedAmount 2022-12-31 iso4217:GBP xbrli:pure

Registration number: 07341143

Cavenagh Health Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 December 2023

 

Cavenagh Health Limited
(Registration number: 07341143)

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 10

 

Cavenagh Health Limited
(Registration number: 07341143)

Company Information

Directors

N Ross

S Murtagh

Registered office

Unit 2 Fordham House
Fordham
Cambridgeshire
CB7 5LL

Registered number

07341143

 

Cavenagh Health Limited
(Registration number: 07341143)

Balance Sheet as at 31 December 2023

Note

2023
£

2022
£

Fixed Assets

 

Intangible assets

4

108,000

-

Tangible Assets

5

30,228

37,785

 

138,228

37,785

Current assets

 

Stocks

-

64,000

Debtors

6

40,279

82,715

Cash at bank and in hand

 

509,645

549,612

 

549,924

696,327

Creditors: Amounts falling due within one year

7

(232,238)

(253,645)

Net current assets

 

317,686

442,682

Total assets less current liabilities

 

455,914

480,467

Creditors: Amounts falling due after more than one year

7

(40,999)

(58,213)

Net assets

 

414,915

422,254

Capital and Reserves

 

Called up share capital

201

1

Retained Earnings

414,714

422,253

Shareholders' funds

 

414,915

422,254

 

Cavenagh Health Limited
(Registration number: 07341143)

Balance Sheet as at 31 December 2023

For the financial year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 18 September 2024 and signed on its behalf by:
 

.........................................
S Murtagh
Director

 

Cavenagh Health Limited
(Registration number: 07341143)

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Unit 2 Fordham House
Fordham
Cambridgeshire
CB7 5LL
England

These financial statements were authorised for issue by the Board on 18 September 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

Cavenagh Health Limited
(Registration number: 07341143)

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible Assets

Tangible Assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Motor Vehicles

20% Reducing Balance

Office equipment

20% Reducing Balance

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Cavenagh Health Limited
(Registration number: 07341143)

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

Trade Debtors

Trade Debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade Debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

 

Cavenagh Health Limited
(Registration number: 07341143)

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 9 (2022 - 9).

 

Cavenagh Health Limited
(Registration number: 07341143)

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

4

Intangible assets

Intangible assets
£

Total
£

Cost

Additions acquired separately

120,000

120,000

At 31 December 2023

120,000

120,000

Amortisation

Amortisation charge

12,000

12,000

At 31 December 2023

12,000

12,000

Carrying amount

At 31 December 2023

108,000

108,000

5

Tangible Assets

Office equipment
£

Motor vehicles
 £

Total
£

Cost

At 1 January 2023

839

47,090

47,929

At 31 December 2023

839

47,090

47,929

Depreciation

At 1 January 2023

98

10,046

10,144

Charge for the year

148

7,409

7,557

At 31 December 2023

246

17,455

17,701

Carrying amount

At 31 December 2023

593

29,635

30,228

At 31 December 2022

741

37,044

37,785

 

Cavenagh Health Limited
(Registration number: 07341143)

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

6

Debtors

The directors have reviewed trade debtors for impairment and consider the impairment losses to be provided for the year are £Nil (2022 - £Nil)

All amounts are due within one year.

Current

2023
£

2022
£

Trade Debtors

24,741

68,218

Prepayments

7,951

11,506

Other debtors

7,587

2,991

 

40,279

82,715

7

Creditors

Creditors: amounts falling due within one year

Note

2023
£

2022
£

Due within one year

 

Loans and borrowings

8

17,215

16,477

Trade creditors

 

51,761

41,282

Taxation and social security

 

161,882

191,142

Accruals and deferred income

 

1,380

1,572

Other creditors

 

-

3,172

 

232,238

253,645

Creditors: amounts falling due after more than one year

Note

2023
£

2022
£

Due after one year

 

Loans and borrowings

8

40,999

58,213

 

Cavenagh Health Limited
(Registration number: 07341143)

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

8

Loans and borrowings

Current loans and borrowings

2023
£

2022
£

Bank borrowings

10,000

10,000

Hire purchase contracts

7,215

6,477

17,215

16,477


 

Non-current loans and borrowings

2023
£

2022
£

Bank borrowings

15,000

25,000

Hire purchase contracts

25,999

33,213

40,999

58,213